Literature DB >> 22487239

Functional analysis of the Notch ligand Jagged1 missense mutant proteins underlying Alagille syndrome.

Minoru Tada1, Satsuki Itoh, Akiko Ishii-Watabe, Takuo Suzuki, Nana Kawasaki.   

Abstract

Heterozygous mutations in the JAG1 gene, encoding Notch ligand Jagged1, cause Alagille syndrome (ALGS). As most of the mutations are nonsense or frameshift mutations producing inactive truncated proteins, haplo-insufficiency is considered the major pathogenic mechanism of ALGS. However, the molecular mechanisms by which the missense mutations cause ALGS remain unclear. Here we analyzed the functional properties of four ALGS missense mutant proteins, P163L, R184H, G386R and C714Y, using transfected mammalian cells. P163L and R184H showed Notch-binding activities similar to that of the wild-type when assessed by immunoprecipitation. However, their trans-activation and cis-inhibition activities were almost completely impaired. These mutant proteins localized mainly to the endoplasmic reticulum (ER), suggesting that the mutations induced improper protein folding. Furthermore, the mutant proteins bound more strongly to the ER chaperone proteins calnexin and calreticulin than the wild-type did. C714Y also localized to the ER, but possessed significant trans-activation activity and lacked enhanced binding to the chaperones, indicating a less severe phenotype. The properties of G386R were the same as those of the wild-type. Dominant-negative effects were not detected for any mutant protein. These results indicate that accumulation in the ER and binding to the chaperones correlate with the impaired signal-transduction activities of the missense mutant proteins, which may contribute to the pathogenic mechanism of ALGS. Our findings, which suggest the requirement for cell-surface localization of Jagged1 for cis-inhibition activities, also provide important information for understanding the molecular basis of Notch-signaling pathways.
© 2012 The Authors Journal compilation © 2012 FEBS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22487239     DOI: 10.1111/j.1742-4658.2012.08595.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  7 in total

Review 1.  Integration of Drosophila and Human Genetics to Understand Notch Signaling Related Diseases.

Authors:  Jose L Salazar; Shinya Yamamoto
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

2.  Experience with genomic sequencing in pediatric patients with congenital cardiac defects in a large community hospital.

Authors:  Natalie S Hauser; Benjamin D Solomon; Thierry Vilboux; Alina Khromykh; Rajiv Baveja; Dale L Bodian
Journal:  Mol Genet Genomic Med       Date:  2018-01-25       Impact factor: 2.183

3.  Alagille syndrome mutation update: Comprehensive overview of JAG1 and NOTCH2 mutation frequencies and insight into missense variant classification.

Authors:  Melissa A Gilbert; Robert C Bauer; Ramakrishnan Rajagopalan; Christopher M Grochowski; Grace Chao; Deborah McEldrew; James A Nassur; Elizabeth B Rand; Bryan L Krock; Binita M Kamath; Ian D Krantz; David A Piccoli; Kathleen M Loomes; Nancy B Spinner
Journal:  Hum Mutat       Date:  2019-08-26       Impact factor: 4.878

Review 4.  Notch Signaling in Kidney Development, Maintenance, and Disease.

Authors:  Malini Mukherjee; Eric Fogarty; Madhusudhana Janga; Kameswaran Surendran
Journal:  Biomolecules       Date:  2019-11-04

5.  Dominant mutations of the Notch ligand Jagged1 cause peripheral neuropathy.

Authors:  Jeremy M Sullivan; William W Motley; Janel O Johnson; William H Aisenberg; Katherine L Marshall; Katy Es Barwick; Lingling Kong; Jennifer S Huh; Pamela C Saavedra-Rivera; Meriel M McEntagart; Marie-Helene Marion; Lucy A Hicklin; Hamid Modarres; Emma L Baple; Mohamed H Farah; Aamir R Zuberi; Cathleen M Lutz; Rachelle Gaudet; Bryan J Traynor; Andrew H Crosby; Charlotte J Sumner
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

6.  Alagille syndrome: Genetics and Functional Models.

Authors:  Melissa A Gilbert; Nancy B Spinner
Journal:  Curr Pathobiol Rep       Date:  2017-09

7.  The effect of epigenetic silencing and TP53 mutation on the expression of DLL4 in human cancer stem disorder.

Authors:  Zhixing Yao; Zaki A Sherif
Journal:  Oncotarget       Date:  2016-09-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.